Alexander J Yan
Overview
Explore the profile of Alexander J Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olson A, Wood R, Weigel K, Yan A, Lochner K, Dragovich R, et al.
J Clin Microbiol
. 2025 Jan;
63(2):e0114024.
PMID: 39745422
Importance: Improved testing for tuberculosis (TB) is needed. Using a more accessible sample type than sputum may enable the detection of more cases, but it is critical that alternative samples...
2.
Yan A, Olson A, Weigel K, Luabeya A, Heiniger E, Hatherill M, et al.
PLoS One
. 2024 Aug;
19(8):e0308235.
PMID: 39146324
Tongue swabs hold promise as a non-invasive sample for diagnosing tuberculosis (TB). However, their utility as replacements for sputum has been limited by their varied diagnostic performance in PCR assays...
3.
Olson A, Wood R, Weigel K, Yan A, Lochner K, Dragovich R, et al.
medRxiv
. 2024 Aug;
PMID: 39108520
Importance: Improved testing for tuberculosis (TB) is needed. Using a more accessible sample type than sputum may enable the detection of more cases, but it is critical that alternative samples...
4.
Ling M, Cardle I, Song K, Yan A, Kacherovsky N, Jensen M, et al.
ACS Biomater Sci Eng
. 2023 Jul;
9(8):5062-5071.
PMID: 37467493
The manufacturing process of chimeric antigen receptor T cell therapies includes isolation systems that provide pure T cells. Current magnetic-activated cell sorting and immunoaffinity chromatography methods produce desired cells with...
5.
Yan V, Pham C, Yan M, Yan A, Khadka S, Arthur K, et al.
bioRxiv
. 2021 Jun;
PMID: 34100016
Despite being FDA-approved for COVID-19, the clinical efficacy of remdesivir (Veklury) remains contentious. We previously pointed out pharmacokinetic, pharmacodynamic and toxicology reasons for why its parent nucleoside GS-441524, is better...